Recombinant adenoviral expression of IL-10 protects beta cell from impairment induced by pro-inflammatory cytokine.

Molecular and Cellular Biochemistry
Ai-Jing XuTang Li

Abstract

Interleukin-10 (IL-10) is a pleiotropic immunosuppressive and immunostimulatory cytokine. In autoimmune diabetes of the nonobese diabetic (NOD) mouse, IL-10 has exhibited paradoxical effects. Systemic IL-10 expression prevented or delayed diabetes onset in NOD mice while local expression of IL-10 did not. As antigen-presenting cells (APCs) play a central role in the generation of primary T cell responses, the direct role of this gene in pancreatic beta (β) cell is not clear. The effects of IL-10 on the protection of β cells in vitro were examined. In the present study, we examined the effects of adenovirus vector-mediated murine IL-10 (mIL-10) gene transfer to islet cell line RINm5F cells in vitro and to explore if IL-10 overexpression may prevent cytokine-mediated cytotoxicity. We had established the recombinant adenovirus vector containing mIL-10 genes (Ad-mIL-10) successfully. After infection of Ad-mIL-10, both mRNA and protein were expressed in RINm5F cells. Moreover, RINm5F cells secreted IL-10 protein into culture medium. Ad-mIL-10 prevented IL-1β-mediated nitric oxide production from β cells in vitro as well as the suppression of β cells function as determined by glucose-stimulated insulin production. Furthermore, Ad-mIL...Continue Reading

References

Dec 1, 1989·The Journal of Experimental Medicine·D F FiorentinoT R Mosmann
May 1, 1994·Clinical Immunology and Immunopathology·K J PennlineM Monahan
Aug 27, 1998·Biochemical Pharmacology·A Rabinovitch, W L Suarez-Pinzon
Oct 7, 1998·Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Métabolisme·M SzelachowskaI Kinalska
Jan 13, 1999·Clinical Immunology : the Official Journal of the Clinical Immunology Society·M Falcone, N Sarvetnick
Mar 13, 2001·Annual Review of Immunology·K W MooreA O'Garra
Jul 31, 2001·Lancet·M A Atkinson, G S Eisenbarth
Oct 10, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·J H ZhouK W Kelley
Nov 22, 2001·Proceedings of the National Academy of Sciences of the United States of America·K GoudyM A Atkinson
Jun 10, 2003·The Journal of Immunology : Official Journal of the American Association of Immunologists·Rima DarwicheThomas W H Kay
Jun 18, 2004·American Journal of Physiology. Cell Physiology·Rajakrishnan VeluthakalAnjaneyulu Kowluru
Oct 13, 2006·American Journal of Physiology. Gastrointestinal and Liver Physiology·Mantej S BharhaniKenneth Croitoru
Sep 1, 2007·Journal of Cellular and Molecular Medicine·Beate KuttlerThomas Ritter
Dec 18, 2007·Journal of Cellular and Molecular Medicine·C HolohanA Samali
Mar 29, 2008·The Journal of Endocrinology·Kleber L A SouzaSigurd Lenzen

❮ Previous
Next ❯

Citations

Jul 30, 2020·Diabetes & Vascular Disease Research : Official Journal of the International Society of Diabetes and Vascular Disease·Mika Yasui-KatoManabu Minami
Oct 18, 2014·Islets·M A Russell, N G Morgan

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis